Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Neurocrine Biosciences completes Daisy Petal trial of elagolix in endometriosis

Nov. 23, 2010

Omthera agrees with FDA on special protocol assessment for Epanova trial

Nov. 23, 2010

Anacetrapib is efficacious and safe in phase III DEFINE trial

Nov. 23, 2010

CTAP-201 shows promise in patients with secondary hyperparathyroidism on hemodialysis

Nov. 23, 2010

Ampla Pharmaceuticals identifies novel cyclic amides

Nov. 22, 2010

Banyu Pharma presents new peptide P518 receptor antagonists

Nov. 19, 2010

Orban Biotech receives Qualifying Therapeutic Discovery grant for IBC-VS01 vaccine

Nov. 19, 2010

Banyu Pharma describes new agonists of bile acid GPBA receptor

Nov. 18, 2010

Juvenile Diabetes Research Foundation and Amylin Pharma partner on metreleptin

Nov. 18, 2010

Takeda patents new modulators of retinol binding protein 4

Nov. 18, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...